Results 61 to 70 of about 1,510 (191)

Development and Method Validation of HPLC Method as an Key Method in the Analysis of Olopatadine HCl [PDF]

open access: yes
Olopatadine hydrochloride (HCl) is a widely used second-generation antihistamine, and its accurate quantification is critical to ensure product quality and therapeutic efficacy.
Arbah, Windy Annisa   +2 more
core   +1 more source

ALLERGIC EYE DISEASES IN CHILDREN. MODERN VIEW ON PATHOGENESIS AND TREATMENT

open access: yesOftalʹmologiâ, 2017
The prevalence off allergic diseases has  been  significantly increased among  adults  and children during last 30-40 years. International study has  shown  that  the  frequency  of atopy  in developed  countries, including Russia,   is higher  than  in ...
E. Y. Markova   +2 more
doaj   +1 more source

A study on the Therapeutic Efficacy of Olopatadine Hydrochloride in the Management of Allergic Conjunctivitis

open access: yes, 1970
A prospective interventional study was conducted to see the efficacy and safety of a ophthalmic preparation olopatadine hydrochloride (0.1%) on 40 allergic conjunctivitis patients attended the out-patient department of Ophthalmology, Sylhet M.A.G. Osmani
Shakhawat Hossain Chowdhury   +3 more
core   +1 more source

A Randomized Prospective Open Label Comparative Study of Olopatadine with Sodium Cromoglycate in Allergic Conjunctivitis [PDF]

open access: yes, 2017
BACKGROUND : Allergic conjunctivitis is the second most common cause of ocular morbidity in India and it accounts about20% of cases attending ophthalmology clinics. Ocular itching and nasal symptoms adversely affect the quality of life of patients. AIM
Sanu, Sain
core  

A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model

open access: yesJournal of Asthma and Allergy, 2013
Stacey Ackerman,1 Francis D’Ambrosio Jr,2 Jack V Greiner,3 Linda Villanueva,4 Joseph B Ciolino,5 David A Hollander41Philadelphia Eye Associates, Philadelphia, PA, 2D’Ambrosio Eye Care, Lancaster, MA, 3Schepens Eye Research Institute ...
Ackerman S   +6 more
doaj  

A prospective study of efficacy and safety of olopatadine versus azelastine in allergic conjunctivitis at a tertiary care hospital [PDF]

open access: yes, 2017
Background: Allergic conjunctivitis, an ocular surface inflammatory disease with significant social and economic impact affects approximately 25% of the general population.
Vijayalakshmi, .   +5 more
core   +1 more source

Olopatadine 0.6% Nasal Spray Protects from Vasomotor Challenge in Patients with Severe Vasomotor Rhinitis

open access: yes, 2011
Background: Vasomotor rhinitis (VMR) is a hypersensitivity syndrome with heightened reactivity to environmental triggers. Methods: Twenty-two patients with severe VMR were treated nasally with either normal saline or 0.6% olopatadine and challenged ...
Collins, Joel   +3 more
core   +1 more source

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis

open access: yesClinical Ophthalmology, 2023
María Cecilia Marini,1 Martín Lucas Berra,2 Fernada Girado,3 Paula Alejandra Albera,4 Melina Sol del Papa,5 María Silvia Passerini,5 Alejandro Javier Aguilar6 1Ophthalmology Service, El Cruce-Nestor Kirchner High Complexity Hospital, Buenos Aires ...
Marini MC   +6 more
doaj  

Stereoselective syntheses of the antihistaminic drug olopatadine and its E-isomer [PDF]

open access: yes, 2017
Practical stereoselective synthetic routes to the antihistaminic drug olopatadine and its E-isomer have been developed, the key steps being a trans stereoselective Wittig olefination using a nonstabilized phosphorus ylide and a stereoselective Heck ...
Bosch Cartes, Joan   +5 more
core   +1 more source

Olopatadine: a drug for allergic conjunctivitis targeting the mast cell

open access: yes, 2010
IMPORTANCE OF THE FIELD: Ocular allergic diseases are characterized by specific activation of conjunctival mast cells with subsequent release of preformed and newly formed mediators.
LEONARDI, ANDREA   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy